Trials
9 active
10 in total · 9 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Each arm will administer different amounts of progesterone vaginally (8mg to 100mg) over a 14-15 day time period.”In the company’s words, NCT06668896 on ClinicalTrials.gov
- Tested for
- Pre Term Birth
- Main trialPhase 1
- “This study is looking for healthy female adults to use an vaginal ring with differing amounts of the hormone progesterone and go through a series of blood draws to measure how much progesterone is in the body following the use of these vaginal rings over an extended period of time.”In the company’s words, NCT06668896 on ClinicalTrials.gov
- Other names
- Progesterone
Coming up1
- Nov 2027Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials10
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Not yet recruiting | Nov 2027 | Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert | |
| Phase 4Authorised | not given | Evaluation of the efficacy of micronized natural progesterone (Seidigestan®) vs GnRH antagonists (Astarté®) in the prevention of LH surge during controlled ovarian stimulation: a randomized clinical trial. | |
| Phase 4Authorised | not given | Progesterone for prEventing Preterm births in women with PlacEnta pRevia (PEPPER-trial) | |
| Phase 4Authorised | not given | Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial | |
| Phase 3Authorised | not given | A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of two formulations of vaginal micronized progesterone. | |
| Phase 4Authorised | not given | Impact of the presence of the corpus luteum on pregnancies obtained through frozen embryo transfer(FET): a prospective randomizedcontrolled study | |
| Phase 2Ended | not given | Exploratory study on the impact of different doses and route of administration of exogenous progesterone in artificial endometrial preparation cycles on endometrial structure and function | |
| Phase 4Authorised | not given | Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer | |
| Phase 4Authorised | not given | Exogenous progesterone as ovulation trigger – a pilot study | |
| Phase 4Authorised | not given | Luteal phase support following letrozole treatment in women undergoing intrauterine insemination: a multicenter randomized trial |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026